![](/img/cover-not-exists.png)
Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors
T. Doi, H. Murakami, A. Ohtsu, N. Fuse, T. Yoshino, N. Yamamoto, N. Boku, Y. Onozawa, C-P. Hsu, K. S. Gorski, G. Friberg, T. Kawaguchi, T. SasakiVolume:
68
Language:
english
Pages:
9
DOI:
10.1007/s00280-010-1544-1
Date:
September, 2011
File:
PDF, 237 KB
english, 2011